We're thrilled to welcome Dr. Amy Abernethy to our BOD! A clinical research pioneer & hematologist-oncologist, her dedication to data-driven healthcare innovation and transformative drug development on behalf of patients align perfectly with our mission. businesswire.com/news/home/2024…

It was great to join Jacob Effron on the Vital Signs podcast. We discussed many topics near to my heart, including what's needed to continue advancing evidence generation, and how AI will fit into that story.

I'm honored to be joining a conversation with Ted Love of @IamBiotech and John Crowley of Amicus Therapeutics, during the 2024 Lake Nona Impact Forum in Orlando, FL. We'll be discussing the cutting edge of drug discovery, and what's needed to advance innovation. #LNIF24

An important part of the @CancerX initiative is their approach to driving innovation across the entire healthcare system. Excited to see how the project will help transform cancer treatment and prevention, and I’m so glad that Verily has joined the partnership.

This new scorecard will help guide innovation post COVID-19. So pleased to have shared my perspective for the report. Read it here: milkeninstitute.org/report/biomedi…

I'm en route to the #PersonalizedMedicine Conference where tomorrow I'll give a keynote, 'Unlocking the Future of Precision Health Through Participant-Centric Evidence Generation'. Looking forward to it!  personalizedmedicineconference.org/sessions/closi…

Proud to collaborate with National Academy of Medicine’s Committee on Emerging Science and Technology on three new case studies covering neurotechnology, telehealth, and regenerative medicine - now available here: doi.org/10.31478/20231…

I look forward to speaking at the  #MIHealthSummit tomorrow on what's needed to continue advancing biomedical innovation, with rberke, Dr. Janet Woodcock, Silvia Taylor, and Christopher Austin.

Can't wait for @CNSsummit next week - I'll join Meg Tirrell for a fireside chat on the current and future state of clinical research, and how biopharma can advance new approaches to benefit patients. Amir Kalali, MD 🌐 @gil_bashe #CNSSummit2023

Yesterday we announced an exciting new partnership with Georgiamune Inc. to advance cancer treatment. This collaboration will combine our expertise in clinical research with Georgiamune’s innovative approach to immunotherapy development.

verily.com/perspectives/g…

Expanding participation in clinical trials is key to generating the evidence needed to advance precision health. ARPA-H's launch of ARPANET-H is an exciting milestone in making clinical trials more accessible to all.

Cell and gene therapies will require new evidence generation approaches to meet regulatory requirements for long term follow-up. This Pink Sheet, Citeline Regulatory article by Kate Rawson Powell covers my remarks at Friends of Cancer Research’s meeting on how we can build what’s needed.

pink.citeline.com/PS148912/CellG…

Terrific to see this latest milestone from our work with
@soseiheptaresco, congrats to the teams!

Thrilled to see the expansion of Verily's Wastewater work through this new contract with CDC.

Yesterday we launched Viewpoint Workbench to help researchers unify multimodal data sets and collaborate securely. We’re excited to welcome our first partners to the platform, Helix, michaeljfox.org and Target ALS!

Congrats to Vindell Washington on this honor!

Vindell has committed his career to advancing health equity. We’re lucky to have him on the Verily team!

I spoke to MM+M Magazine about the current real-world data landscape, and how Verily is working on solutions to generate high-quality and reliable RWD.

Look forward to speaking at #HLTH2023 alongside Scott Gottlieb, MD, Susan Coller Monarez, & Bill Geary.

Join us on Monday, 10/9 for a discussion on FDA and modernizing evidence generation.

hlth.com/2023event/agen…

Excited to share this brand update as we continue to unify our product portfolio around bridging the gap between research and care. Go team!

'Data consent needs to match the complexity and risk of the test.' @verily's Dr. Amy Abernethy Amy Abernethy talking about #RWE with Steve Usdin steve usdin BioCentury

Join live: youtube.com/watch?v=39lGyP…

#RWE Friends #RWD